Home›Companies›Healthcare›Aethl Bio

Aethl Bio, Inc.

Develops wound dressings for people with chronic wounds.

Updated Nov 10, 2026·Latest SEC filing Apr 17, 2026·Suggest an edit

About Aethl Bio

Aethl Bio is a private company based in Pittsburgh, Pennsylvania, incorporated in 2025 in Delaware. It has reported $1,635,000 raised in one offering on Form D since April 2026. Its chief executive is Carmelo Montalvo.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 14, 2025Apr 17, 2026$1,635,000of $5.0M target8$204KSecurities on exercise, Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aethl Bio's Form D filed Apr 17, 2026.

Zachary Richert
Zachary Richert
VP Strategy and director
Melissa Thompson
Melissa Thompson
Chief Compliance Officer
Carmelo Montalvo
Carmelo Montalvo
Chief Executive Officer and director
Dan Willis
Dan Willis
Chief Technology Officer

Sources

  1. SECAethl Bio, Inc. filing history
  2. CompanyAethl Bio team
  3. PressAethl Bio advisor announcement